Yat Sun Or
Net Worth

Last updated:

What is Yat Sun Or net worth?

The estimated net worth of Dr. Yat Sun Or is at least $19,021,031 as of 6 Dec 2024. He owns shares worth $3,096,825 as insider, has earned $8,493,926 from insider trading and has received compensation worth at least $7,430,280 in Enanta Pharmaceuticals, Inc..

What is the salary of Yat Sun Or?

Dr. Yat Sun Or salary is $675,480 per year as Senior Vice President of R&D and Chief Scientific Officer in Enanta Pharmaceuticals, Inc..

How old is Yat Sun Or?

Dr. Yat Sun Or is 73 years old, born in 1952.

What stocks does Yat Sun Or currently own?

As insider, Dr. Yat Sun Or owns shares in one company:

Company Title Shares Price per share Total value
Enanta Pharmaceuticals, Inc. (ENTA) Senior Vice President of R&D and Chief Scientific Officer 369,109 $8.39 $3,096,825

What does Enanta Pharmaceuticals, Inc. do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

ENTA logo
ENTA
Enanta Pharmaceuticals, Inc.
$8.39

Yat Sun Or insider trading

Enanta Pharmaceuticals, Inc.

Dr. Yat Sun Or has made 20 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,591 units of ENTA stock worth $20,883 on 6 Dec 2024.

The largest trade he's ever made was exercising 129,087 units of ENTA stock on 3 Jan 2014. As of 6 Dec 2024 he still owns at least 369,109 units of ENTA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,591 $8.06 $20,883
Sale
Common Stock 2,412 $9.63 $23,228
Sale
Common Stock 269 $43.92 $11,814
Option
Stock Option (Right to Buy) 13,925 $14 $194,950
Sale
Common Stock 13,656 $44.46 $607,146
Option
Common Stock 13,925 $14 $194,950
Option
Common Stock 13,693 $12.57 $172,162
Option
Stock Option (Right to Buy) 5,149 $14.18 $73,013
Option
Common Stock 13,693 $12.57 $172,162
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Units 5,250 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Units 5,250 N/A N/A
Sale
Common Stock 10,000 $103.58 $1,035,790
Sale
Common Stock 6,297 $90.07 $567,171
Option
Stock Option (Right to Buy) 25,977 $13.32 $345,936
Sale
Common Stock 27,684 $89.88 $2,488,155
Option
Common Stock 25,977 $13.32 $345,936
Sale
Common Stock 13,921 $35.09 $488,502
Sale
Common Stock 13,921 $31.44 $437,607
Option
Stock Option (right to buy) 13,921 $2.54 $35,401
Option
Common Stock 42,922 $2.54 $109,151
Option
Common Stock 78,565 $2 $156,894
Option
Stock Option (right to buy) 50,723 $2.97 $150,850
Sale
Common Stock 3,750 $42.96 $161,100
Sale
Common Stock 3,750 $46.4 $174,000
Sale
Common Stock 3,750 $42.47 $159,266
Sale
Common Stock 10,750 $42.02 $451,661
Sale
Common Stock 8,000 $36.13 $289,048
Option
Common Stock 58,004 $1.21 $70,011
Option
Stock Option (right to buy) 6,960 $1.21 $8,401
Sale
Common Stock 5,000 $39.76 $198,795
Option
Stock Option (right to buy) 11,149 $1.29 $14,416
Option
Common Stock 11,149 $1.29 $14,416
Sale
Common Stock 5,000 $42.59 $212,935
Sale
Common Stock 5,000 $37.76 $188,800
Sale
Common Stock 5,000 $36.76 $183,795
Sale
Common Stock 10,000 $39.95 $399,450
Sale
Common Stock 10,000 $39.48 $394,780
Option
Common Stock 129,087 $0.73 $94,621
Option
Stock Option (right to buy) 121,837 $0.73 $89,307

Enanta Pharmaceuticals key executives

Enanta Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: